Knight Therapeutics Inc. (TSX: GUD)
5.73
+0.02 (0.35%)
Jul 19, 2024, 4:00 PM EDT
Knight Therapeutics Revenue
Knight Therapeutics had revenue of 332.21M CAD in the twelve months ending March 31, 2024, with 6.36% growth year-over-year. Revenue in the quarter ending March 31, 2024 was 86.60M with 4.85% year-over-year growth. In the year 2023, Knight Therapeutics had annual revenue of 328.20M with 11.80% growth.
Revenue (ttm)
332.21M
Revenue Growth
+6.36%
P/S Ratio
1.81
Revenue / Employee
458.22K
Employees
725
Market Cap
580.61M CAD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 328.20M | 34.64M | 11.80% |
Dec 31, 2022 | 293.56M | 50.09M | 20.57% |
Dec 31, 2021 | 243.48M | 43.96M | 22.03% |
Dec 31, 2020 | 199.52M | 152.06M | 320.39% |
Dec 31, 2019 | 47.46M | 34.96M | 279.69% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch + Lomb Corporation | 5.92B |
Curaleaf Holdings, Inc. | 1.83B |
Bausch Health Companies Inc. | 12.14B |
Tilray Brands, Inc. | 1.01B |
WELL Health Technologies Corp. | 838.19M |
Sienna Senior Living Inc. | 824.26M |
Canopy Growth Corporation | 297.15M |
Extendicare Inc. | 1.35B |
Knight Therapeutics News
- 2 months ago - Knight Therapeutics reports Q1 results - Seeking Alpha
- 2 months ago - Knight Therapeutics Reports First Quarter 2024 Results - GlobeNewsWire
- 2 months ago - Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America - GlobeNewsWire
- 2 months ago - Knight Therapeutics Inc. announces voting results from the Annual General Meeting - GlobeNewsWire
- 2 months ago - Notice of Knight Therapeutics’ First Quarter 2024 Results Conference Call - Financial Post
- 2 months ago - Notice of Knight Therapeutics' First Quarter 2024 Results Conference Call - GlobeNewsWire
- 4 months ago - Knight Therapeutics Inc. (KHTRF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Knight Therapeutics GAAP EPS of -C$0.23, revenue of C$74.2M - Seeking Alpha